Owners, management and financials
CVR: 13526990
Secondary names: BOEHRINGER INGELHEIM ANIMAL HEALTH NORDICS A/S, BOEHRINGER INGELHEIM AGROVET A/S, BOEHRINGER INGELHEIM VETMEDICA A/S
Previous names: SLP NR. 10.530 A/S, RHONE MERIEUX NORDEN A/S, MERIAL NORDEN A/S
DKK 725,936,000
Revenue
Net result: DKK -3,950,000
Boehringer Ingelheim Animal Health International GmbH (100%)
CVR · view owners
Dirk Neven Rauleder
Board: Ksenija Setlere (chair) and 2 members
CVR · view management
Active
Founded 1 October 1989
CVR · view overview
98 employees
CVR · 2026
Director role ended: Niels Berenth From
CVR · 01/09/2024
View the full event history
Boehringer Ingelheim Animal Health Denmark A/S is a Danish company of the type Aktieselskab based in København S, founded in 1989. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named MERIAL NORDEN A/S and RHONE MERIEUX NORDEN A/S. The management consists of Dirk Neven Rauleder. The board consists of Ksenija Setlere (chair), Dirk Neven Rauleder and Joey Dirker. The company is owned by Boehringer Ingelheim Animal Health International GmbH. The company has 98 employees (2026). In 2025, the company reported revenue of DKK 725,936,000 and a net result of DKK -3,950,000 compared with DKK 40,407,000 the year before. Equity in the 2025 report amounted to DKK 90,111,000.
Source: annual report 2025, Danish Business Authority
The financial health of Boehringer Ingelheim Animal Health Denmark A/S appears to be under pressure, as evidenced by a significant decline in profitability, with a reported loss of 3,950,000 DKK in 2025 following a profit of 40,407,000 DKK in 2024. Revenue has shown a steady increase from 585,336,000 DKK in 2023 to 725,936,000 DKK in 2025, indicating a positive sales trajectory despite the recent profit downturn. Equity has decreased from 113,624,000 DKK in 2024 to 90,111,000 DKK in 2025, raising concerns about the company's financial stability and ability to sustain operations. Positioned within the pharmaceutical wholesale industry, the company faces challenges in maintaining healthy profit margins and managing its equity effectively.
AI-generated summary · Generated 18/06/2026
Selskabets formål er enhver aktivitet i forbindelse med salgsfremmende virksomhed og distribution samt produk- tion og forskning og enhver anden beslægtet aktivitet inden for animalsk sundhed.
Source: annual reports filed with the Danish Business Authority.
| Period | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | 725.9M | -4M | 364.3M | 90.1M | 90000 | |
| 202401/01/2024 – 31/12/2024 | 634.4M | 40.4M | 404.6M | 113.6M | 93000 | |
| 202301/01/2023 – 31/12/2023 | 585.3M | 14.5M | 370.8M | 98.6M | 92000 | |
| 202201/01/2022 – 31/12/2022 | 587.5M | 17.5M | 321M | 94M | 96 | |
| 202101/01/2021 – 31/12/2021 | 588.5M | 25M | 390.1M | 77.1M | 103 | |
| 202001/01/2020 – 31/12/2020 | 622.6M | 51.2M | 283M | 98.2M | 109 | |
| 201901/01/2019 – 31/12/2019 | 596.5M | -21.1M | 343.9M | 46.7M | 112 | |
| 201801/01/2018 – 31/12/2018 | 573.7M | 7.6M | 389.2M | 70.5M | 114 | |
| 201701/01/2017 – 31/12/2017 | 615M | 628.8M | 794.6M | 687.5M | 31 | |
| 201601/01/2016 – 31/12/2016 | - | 3.9M | 105.9M | 27.6M | 31 | |
| 201501/01/2015 – 31/12/2015 | - | 3.7M | 57.7M | 23.7M | 35 | |
| 201401/01/2014 – 31/12/2014 | - | 5.8M | 60.1M | 20M | 29 | |
| 201301/01/2013 – 31/12/2013 | - | 6.4M | 55M | 20.2M | 29 |
Compared to 403 companies in Engroshandel med medicinalvarer og sygeplejeartikler
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorThe CVR number of Boehringer Ingelheim Animal Health Denmark A/S is 13526990.
Boehringer Ingelheim Animal Health Denmark A/S is owned by Boehringer Ingelheim Animal Health International GmbH.
The management of Boehringer Ingelheim Animal Health Denmark A/S consists of Dirk Neven Rauleder.
The board of Boehringer Ingelheim Animal Health Denmark A/S consists of Ksenija Setlere, Dirk Neven Rauleder and Joey Dirker, with Ksenija Setlere as chair.
In 2025, Boehringer Ingelheim Animal Health Denmark A/S reported revenue of DKK 725,936,000.
Boehringer Ingelheim Animal Health Denmark A/S had 98 employees in 2026 according to the Danish CVR register.
Claim this page to add your logo and social links. Free to get started.
Contact info changed: new phone: 39158888, new website: https://www.boehringer-ingelheim.dk/ (August 10, 2026).
As of August 1, 2026, Ksenija Setlere has joined the board of directors of Boehringer Ingelheim Animal Health Denmark A/S.
As of August 1, 2026, Joey Dirker has joined the board of directors of Boehringer Ingelheim Animal Health Denmark A/S.
As of August 1, 2026, Nick Lee Munch Øgendahl has left the board of directors of Boehringer Ingelheim Animal Health Denmark A/S.
As of August 1, 2026, Marianne Delic has left the board of directors of Boehringer Ingelheim Animal Health Denmark A/S.
Contact info changed: new phone: 39158888, new website: https://www.boehringer-ingelheim.dk/ (June 20, 2026).
Contact info changed: new phone: 39158888, new website: https://www.boehringer-ingelheim.dk/ (June 19, 2026).
As of June 19, 2026, Nick Lee Munch Øgendahl has joined the board of directors of Boehringer Ingelheim Animal Health Denmark A/S.
As of June 19, 2026, Marianne Delic has joined the board of directors of Boehringer Ingelheim Animal Health Denmark A/S.
As of June 19, 2026, Stephen Mark Wright has left the board of directors of Boehringer Ingelheim Animal Health Denmark A/S.
As of June 19, 2026, Angelika Anna Kirchen has left the board of directors of Boehringer Ingelheim Animal Health Denmark A/S.
Boehringer Ingelheim Animal Health Denmark A/S has published its annual report for 2025. Revenue came to DKK 725,936,000, and the net result was DKK -3,950,000.
Boehringer Ingelheim Animal Health Denmark A/S has published its annual report for 2024. Revenue came to DKK 634,426,000, and the net result was DKK 40,407,000.
As of January 13, 2025, Angelika Anna Kirchen has joined the board of directors of Boehringer Ingelheim Animal Health Denmark A/S.
As of November 1, 2024, Niko Rodio has left the board of directors of Boehringer Ingelheim Animal Health Denmark A/S.
As of September 1, 2024, Dirk Neven Rauleder has joined the board of directors of Boehringer Ingelheim Animal Health Denmark A/S.
As of September 1, 2024, Niels Berenth From has left the board of directors of Boehringer Ingelheim Animal Health Denmark A/S.
As of September 1, 2024, Dirk Neven Rauleder is registered as adm. dir. of Boehringer Ingelheim Animal Health Denmark A/S.
As of September 1, 2024, Niels Berenth From has stepped down as adm. dir. of Boehringer Ingelheim Animal Health Denmark A/S.
Boehringer Ingelheim Animal Health Denmark A/S has published its annual report for 2023. Revenue came to DKK 585,336,000, and the net result was DKK 14,503,000.
Boehringer Ingelheim Animal Health Denmark A/S has published its annual report for 2022. Revenue came to DKK 587,463,000, and the net result was DKK 17,459,000.
As of June 16, 2022, Niko Rodio has joined the board of directors of Boehringer Ingelheim Animal Health Denmark A/S.
As of June 16, 2022, Stephen Mark Wright has joined the board of directors of Boehringer Ingelheim Animal Health Denmark A/S.
As of June 16, 2022, Nicolas Charles Dumoulin has left the board of directors of Boehringer Ingelheim Animal Health Denmark A/S.
As of June 15, 2022, Niko Rodio has left the board of directors of Boehringer Ingelheim Animal Health Denmark A/S.
Boehringer Ingelheim Animal Health Denmark A/S has published its annual report for 2021. Revenue came to DKK 588,519,000, and the net result was DKK 25,014,000.
As of November 19, 2021, Niko Rodio has joined the board of directors of Boehringer Ingelheim Animal Health Denmark A/S.
As of November 19, 2021, Thomas Heinrich has left the board of directors of Boehringer Ingelheim Animal Health Denmark A/S.
As of September 4, 2020, is registered as an owner of Boehringer Ingelheim Animal Health Denmark A/S with an ownership share of 100%.
Boehringer Ingelheim Animal Health Denmark A/S has published its annual report for 2019. Revenue came to DKK 596,526,000, and the net result was DKK -21,145,000.
As of October 28, 2019, Thomas Heinrich has joined the board of directors of Boehringer Ingelheim Animal Health Denmark A/S.
As of October 28, 2019, Matthias Hasenauer has left the board of directors of Boehringer Ingelheim Animal Health Denmark A/S.
Boehringer Ingelheim Animal Health Denmark A/S has published its annual report for 2018. Revenue came to DKK 573,663,000, and the net result was DKK 7,631,000.
As of February 26, 2019, Nicolas Charles Dumoulin has joined the board of directors of Boehringer Ingelheim Animal Health Denmark A/S.
As of February 25, 2019, Nedim Pipic has left the board of directors of Boehringer Ingelheim Animal Health Denmark A/S.
As of November 28, 2018, Matthias Hasenauer has joined the board of directors of Boehringer Ingelheim Animal Health Denmark A/S.
As of November 27, 2018, Jesper Peulicke has left the board of directors of Boehringer Ingelheim Animal Health Denmark A/S.
Boehringer Ingelheim Animal Health Denmark A/S has published its annual report for 2017. Revenue came to DKK 615,004,000, and the net result was DKK 628,833,000.
As of June 4, 2018, KPMG P/S has been appointed auditor of Boehringer Ingelheim Animal Health Denmark A/S.
As of June 4, 2018, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of Boehringer Ingelheim Animal Health Denmark A/S.
On January 1, 2018, the company changed its name from MERIAL NORDEN A/S to Boehringer Ingelheim Animal Health Denmark A/S.
As of September 25, 2017, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of Boehringer Ingelheim Animal Health Denmark A/S.
As of September 25, 2017, EY Godkendt Revisionspartnerselskab has stepped down as auditor of Boehringer Ingelheim Animal Health Denmark A/S.
Boehringer Ingelheim Animal Health Denmark A/S has published its annual report for 2016. Gross profit came to DKK 39,000,000, and the net result was DKK 3,876,000.
As of April 30, 2017, Jesper Peulicke has joined the board of directors of Boehringer Ingelheim Animal Health Denmark A/S.
As of April 30, 2017, Nedim Pipic has joined the board of directors of Boehringer Ingelheim Animal Health Denmark A/S.
As of April 30, 2017, Pierluigi Crippa has left the board of directors of Boehringer Ingelheim Animal Health Denmark A/S.
As of April 29, 2017, Nedim Pipic has left the board of directors of Boehringer Ingelheim Animal Health Denmark A/S.
As of March 31, 2017, Niels Berenth From has joined the board of directors of Boehringer Ingelheim Animal Health Denmark A/S.
As of March 31, 2017, Niels Berenth From is registered as adm. dir. of Boehringer Ingelheim Animal Health Denmark A/S.
As of March 6, 2017, Karsien Elzo ten Have has left the board of directors of Boehringer Ingelheim Animal Health Denmark A/S.
As of March 6, 2017, Karsien Elzo ten Have has stepped down as director of Boehringer Ingelheim Animal Health Denmark A/S.
As of January 31, 2017, Nedim Pipic has joined the board of directors of Boehringer Ingelheim Animal Health Denmark A/S.
As of January 31, 2017, Kirstin Jagd has left the board of directors of Boehringer Ingelheim Animal Health Denmark A/S.
As of December 1, 2016, Pierluigi Crippa has joined the board of directors of Boehringer Ingelheim Animal Health Denmark A/S.
As of December 1, 2016, Peter Sjoerd Kuiper has left the board of directors of Boehringer Ingelheim Animal Health Denmark A/S.
Boehringer Ingelheim Animal Health Denmark A/S has published its annual report for 2015. The net result was DKK 3,679,000.
Boehringer Ingelheim Animal Health Denmark A/S has published its annual report for 2014. Gross profit came to DKK 67,241,986, and the net result was DKK 5,823,204.
As of October 10, 2014, EY Godkendt Revisionspartnerselskab has been appointed auditor of Boehringer Ingelheim Animal Health Denmark A/S.
As of October 10, 2014, JUT NR. 2180 A/S has stepped down as auditor of Boehringer Ingelheim Animal Health Denmark A/S.
Boehringer Ingelheim Animal Health Denmark A/S has published its annual report for 2013. Gross profit came to DKK 67,122,372, and the net result was DKK 6,409,804.
As of May 23, 2014, Kirstin Jagd has joined the board of directors of Boehringer Ingelheim Animal Health Denmark A/S.
As of May 23, 2014, Ann Jensen has left the board of directors of Boehringer Ingelheim Animal Health Denmark A/S.
Boehringer Ingelheim Animal Health Denmark A/S has published its annual report for 2012.
As of December 10, 2012, JUT NR. 2180 A/S has been appointed auditor of Boehringer Ingelheim Animal Health Denmark A/S.
As of December 10, 2012, EY Danmark A/S has stepped down as auditor of Boehringer Ingelheim Animal Health Denmark A/S.
As of May 15, 2012, EY Danmark A/S has been appointed auditor of Boehringer Ingelheim Animal Health Denmark A/S.
As of May 15, 2012, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of Boehringer Ingelheim Animal Health Denmark A/S.
As of February 20, 2012, Ann Jensen has joined the board of directors of Boehringer Ingelheim Animal Health Denmark A/S.
As of February 20, 2012, Karsien Elzo ten Have has joined the board of directors of Boehringer Ingelheim Animal Health Denmark A/S.
As of February 20, 2012, Peter Sjoerd Kuiper has joined the board of directors of Boehringer Ingelheim Animal Health Denmark A/S.
As of February 20, 2012, Anders Torbøl has left the board of directors of Boehringer Ingelheim Animal Health Denmark A/S.
As of February 20, 2012, Phillippe Martin Jarrand has left the board of directors of Boehringer Ingelheim Animal Health Denmark A/S.
As of February 20, 2012, Pierre Aubrun has left the board of directors of Boehringer Ingelheim Animal Health Denmark A/S.
As of February 20, 2012, Jean-Louis Patrick Crosia has left the board of directors of Boehringer Ingelheim Animal Health Denmark A/S.
As of January 1, 2012, Karsien Elzo ten Have is registered as director of Boehringer Ingelheim Animal Health Denmark A/S.
As of January 1, 2012, Per-Olof Nilsson has stepped down as director of Boehringer Ingelheim Animal Health Denmark A/S.
As of July 1, 2011, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of Boehringer Ingelheim Animal Health Denmark A/S.
As of July 1, 2011, A/S PSE NR. 4820 has stepped down as auditor of Boehringer Ingelheim Animal Health Denmark A/S.
As of October 9, 2007, Anders Torbøl has joined the board of directors of Boehringer Ingelheim Animal Health Denmark A/S.
As of October 9, 2007, Jean-Louis Patrick Crosia has joined the board of directors of Boehringer Ingelheim Animal Health Denmark A/S.
As of May 30, 2007, A/S PSE NR. 4820 has been appointed auditor of Boehringer Ingelheim Animal Health Denmark A/S.
As of May 30, 2007, Pricewaterhouse Coopers has stepped down as auditor of Boehringer Ingelheim Animal Health Denmark A/S.
As of February 16, 2007, Per-Olof Nilsson is registered as director of Boehringer Ingelheim Animal Health Denmark A/S.
As of February 16, 2007, Pierre Aubrun has stepped down as director of Boehringer Ingelheim Animal Health Denmark A/S.
As of April 20, 2006, Daniel Jean Michel Gouffe has left the board of directors of Boehringer Ingelheim Animal Health Denmark A/S.
As of September 30, 2005, Pierre Aubrun has joined the board of directors of Boehringer Ingelheim Animal Health Denmark A/S.
As of September 30, 2005, David Alexander Biland has left the board of directors of Boehringer Ingelheim Animal Health Denmark A/S.
As of September 30, 2005, Graham Davenport has left the board of directors of Boehringer Ingelheim Animal Health Denmark A/S.
As of September 30, 2005, Pierre Aubrun is registered as director of Boehringer Ingelheim Animal Health Denmark A/S.
As of September 30, 2005, Graham Davenport has stepped down as adm. dir. of Boehringer Ingelheim Animal Health Denmark A/S.
As of April 26, 2004, Daniel Jean Michel Gouffe has joined the board of directors of Boehringer Ingelheim Animal Health Denmark A/S.
As of April 26, 2004, Graham Davenport has joined the board of directors of Boehringer Ingelheim Animal Health Denmark A/S.
As of April 26, 2004, Graham Davenport is registered as adm. dir. of Boehringer Ingelheim Animal Health Denmark A/S.
As of April 26, 2004, David Alexander Biland has stepped down as adm. dir. of Boehringer Ingelheim Animal Health Denmark A/S.
As of September 12, 2003, Alan Reade has left the board of directors of Boehringer Ingelheim Animal Health Denmark A/S.
As of September 25, 2002, David Alexander Biland has joined the board of directors of Boehringer Ingelheim Animal Health Denmark A/S.
As of September 25, 2002, David Hinton has left the board of directors of Boehringer Ingelheim Animal Health Denmark A/S.
As of September 25, 2002, David Alexander Biland is registered as adm. dir. of Boehringer Ingelheim Animal Health Denmark A/S.
As of September 25, 2002, David Hinton has stepped down as director of Boehringer Ingelheim Animal Health Denmark A/S.
As of June 21, 2000, Alan Reade has joined the board of directors of Boehringer Ingelheim Animal Health Denmark A/S.
As of June 21, 2000, David Hinton has joined the board of directors of Boehringer Ingelheim Animal Health Denmark A/S.
As of June 21, 2000, Phillippe Martin Jarrand has joined the board of directors of Boehringer Ingelheim Animal Health Denmark A/S.
As of June 21, 2000, Alexandre Philippe Sudarskis has left the board of directors of Boehringer Ingelheim Animal Health Denmark A/S.
As of June 21, 2000, Louis Joseph Rene Champel has left the board of directors of Boehringer Ingelheim Animal Health Denmark A/S.
As of June 21, 2000, David Hinton is registered as director of Boehringer Ingelheim Animal Health Denmark A/S.
As of June 21, 2000, Alexandre Philippe Sudarskis has stepped down as director of Boehringer Ingelheim Animal Health Denmark A/S.
As of January 15, 2000, Thierry Descollonges has left the board of directors of Boehringer Ingelheim Animal Health Denmark A/S.
As of December 18, 1997, Alexandre Philippe Sudarskis has joined the board of directors of Boehringer Ingelheim Animal Health Denmark A/S.
As of December 18, 1997, Louis Joseph Rene Champel has joined the board of directors of Boehringer Ingelheim Animal Health Denmark A/S.
As of December 18, 1997, Anders Torbøl has left the board of directors of Boehringer Ingelheim Animal Health Denmark A/S.
As of October 7, 1997, Alexandre Philippe Sudarskis is registered as director of Boehringer Ingelheim Animal Health Denmark A/S.
As of October 7, 1997, Leo Ørtenblad has stepped down as director of Boehringer Ingelheim Animal Health Denmark A/S.
On September 5, 1997, the company changed its name from RHONE MERIEUX NORDEN A/S to MERIAL NORDEN A/S.
As of November 2, 1993, Jerome Paul Gustave Gervais has left the board of directors of Boehringer Ingelheim Animal Health Denmark A/S.
As of May 13, 1992, Louis Marie Cottin has left the board of directors of Boehringer Ingelheim Animal Health Denmark A/S.
As of May 29, 1991, Frantz Johannes Dahl has left the board of directors of Boehringer Ingelheim Animal Health Denmark A/S.
As of May 29, 1991, Anders Torbøl has stepped down as director of Boehringer Ingelheim Animal Health Denmark A/S.
On July 10, 1990, the company changed its name from SLP NR. 10.530 A/S to RHONE MERIEUX NORDEN A/S.
As of July 9, 1990, DANSK REVISION I AALBORG A/S has stepped down as auditor of Boehringer Ingelheim Animal Health Denmark A/S.
As of July 9, 1990, Preben Bang Henriksen has left the board of directors of Boehringer Ingelheim Animal Health Denmark A/S.
As of July 9, 1990, Mogens Gaardboe Bertelsen has left the board of directors of Boehringer Ingelheim Animal Health Denmark A/S.
As of July 9, 1990, Lone Mai Henriksen has left the board of directors of Boehringer Ingelheim Animal Health Denmark A/S.
As of July 9, 1990, Preben Bang Henriksen has stepped down as director of Boehringer Ingelheim Animal Health Denmark A/S.
As of October 1, 1989, Pricewaterhouse Coopers has been appointed auditor of Boehringer Ingelheim Animal Health Denmark A/S.
As of October 1, 1989, DANSK REVISION I AALBORG A/S has been appointed auditor of Boehringer Ingelheim Animal Health Denmark A/S.
As of October 1, 1989, Frantz Johannes Dahl has joined the board of directors of Boehringer Ingelheim Animal Health Denmark A/S.
As of October 1, 1989, Preben Bang Henriksen has joined the board of directors of Boehringer Ingelheim Animal Health Denmark A/S.
As of October 1, 1989, Mogens Gaardboe Bertelsen has joined the board of directors of Boehringer Ingelheim Animal Health Denmark A/S.
As of October 1, 1989, Anders Torbøl has joined the board of directors of Boehringer Ingelheim Animal Health Denmark A/S.
As of October 1, 1989, Louis Marie Cottin has joined the board of directors of Boehringer Ingelheim Animal Health Denmark A/S.
As of October 1, 1989, Lone Mai Henriksen has joined the board of directors of Boehringer Ingelheim Animal Health Denmark A/S.
As of October 1, 1989, Jerome Paul Gustave Gervais has joined the board of directors of Boehringer Ingelheim Animal Health Denmark A/S.
As of October 1, 1989, Thierry Descollonges has joined the board of directors of Boehringer Ingelheim Animal Health Denmark A/S.
As of October 1, 1989, Preben Bang Henriksen is registered as director of Boehringer Ingelheim Animal Health Denmark A/S.
As of October 1, 1989, Leo Ørtenblad is registered as director of Boehringer Ingelheim Animal Health Denmark A/S.
As of October 1, 1989, Anders Torbøl is registered as director of Boehringer Ingelheim Animal Health Denmark A/S.
Boehringer Ingelheim Animal Health Denmark A/S was founded on October 1, 1989.
Uneven Bits ApS is an independent IT consultancy founded and operated by Klaus Byskov Pedersen. With deep expertise in software architecture and systems design, I help organizations build robust, scalable, and maintainable technical solutions. Whether you need strategic guidance on technology decisions, hands-on architecture work, or help navigating complex technical challenges, I bring focused expertise and a practical approach to every engagement.
Selskabets formål er at udvikle, markedsføre, sælge og implementere software produkter til brug ved indkøbsstyring og dermed efter bestyrelsens skøn beslægtet virksomhed
Selskabets formål er at drive virksomhed med handel og produktion samt hermed beslægtet virksomhed.
Selskabets formål er IT- og kommunikationsvirksomhed samt virksomhed i øvrigt, der efter bestyrelsens skøn står i forbindelse hermed.
Companies in the same industry and area
CVR 41183144
CVR 35451307
CVR 36392398
CVR 14479880
CVR 37626619
